Miracle cure: Wockhardt’s experimental drug defeats deadly superbug in dramatic recovery

Pallavi Madhiraju- September 19, 2024

Wockhardt Limited announced that its investigational drug Zaynich (Zidebactam/Cefepime) has successfully treated a complex case of bacterial meningitis caused by a pan-drug-resistant superbug under compassionate ... Read More

Sebi chief Madhabi Puri Buch hits back at Congress, exposes ‘illegal’ tactics to frame narrative

Pallavi Madhiraju- September 13, 2024

The Securities and Exchange Board of India (SEBI) chief Madhabi Puri Buch and her husband Dhaval Buch have responded to the Congress Party's accusations of ... Read More

Wockhardt makes breakthrough in pneumonia treatment with Nafithromycin WCK 4873

Pallavi Madhiraju- December 17, 2023

Wockhardt is proud to announce the successful completion of its pivotal Phase 3 pneumonia study involving the macrolide antibiotic Nafithromycin WCK 4873. This significant achievement ... Read More

Wockhardt, Serum Life Sciences partner to manufacture vaccines in UK

pallavi123- March 20, 2022

Wockhardt Limited said that it has signed a collaboration agreement through its subsidiary with Serum Life Sciences Ltd, UK, which in turn is a subsidiary ... Read More

Wockhardt, RDIF strike deal with for Sputnik V and Sputnik Light vaccines

pallavi123- August 18, 2021

The Russian Direct Investment Fund (RDIF), the Russian sovereign wealth fund, has entered into a partnership with Indian pharma company Wockhardt Limited for producing and ... Read More